Mountain View, Calif.-based Livongo, a digital health platform for chronic disease management that went public in July, released its second quarter earnings report on Sept. 5, showing sizable gains in revenue and membership.
Livongo's second quarter revenue totaled $40.9 million, a year-over-year increase of 156 percent. Additionally, the number of members enrolled in the Livongo for Diabetes program surged 140 percent year-over-year, adding more than 38,000 new members to reach a total of 192,934.
Per the report, in the third quarter, Livongo expects to see revenues of $42 million to $43 million. Revenue for the entire year is expected to reach up to $162 million. The report, which spans the three months ending June 30, comes in the wake of Livongo's $355 million initial public offering on July 25.
"Livongo serves the whole person across multiple chronic conditions by uniquely combining technology and data science with a human touch. This empowers our members to manage their chronic conditions on their own terms," Livongo President Jennifer Schneider, MD, said in a statement. "During the quarter, Livongo continued to demonstrate the rigor and discipline required to produce academic studies that prove the effectiveness of our clinically based programs and ability to drive meaningful behavior change in our members."
More articles on health IT:
Montana developing $19M statewide HIE
Kaiser Permanente joins $35M funding for virtual mental health startup
Physician viewpoint: 10 areas in which AI will transform primary care